The first liver transplantation in Asia performed by Nakayama from Japan dates back to 1964, just one year after Thomas Strazl's first liver transplant in United States. Even though an initiative was taken long ago, none of the early programs in Asia had real momentum to flourish and less than 5% of world transplants were performed in Asia until the turn of the century. Considering the fact that 60% of the world population resides in the Asian region together with high prevalence of endemic liver disease, this seems a minute number [1] . Slow progression of these initial programs towards success was primarily due to the lack of cadaveric organs. However, the momentum of liver transplantation started changing with the recognition of living donor liver transplantation (LDLT) as an effective alternative for organ shortage by Asian surgeons. Though 
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programs to maintain a sustainable increase in cadaveric donation. Non-acceptance of the concept of brain death among Asian communities has also been a major setback. In South Asian countries, lack of infrastructural support for organ retrieval greatly effects timely retrieval of the graft. On the other hand, close bonding among family members and extended family support in Asian societies has influenced the popularity of live donation. Considering this cultural, social and economic background unique to the region, LDLT has flourished as an effective alternative.
The concept of partial graft being a marginal graft compared to a total graft has been consistently disproved by results from Asia. Data from our centre have shown that partial grafts used in high urgency patients with acute liver failure produce similar results to cadaveric organs [5, 6] . Additionally, the overall patient survival and graft survival has been clearly shown to be comparable or even better after LDLT [7] . Primary non function rates are below 0.13% after LDLT probably due to shorter ischemic time. Beneficial effects on survival due to very short or no waiting time in semi urgent and urgent indications like tumors and fulminant hepatic failure should be added to this list.
In general, for right lobe donation, reported donor mortality figures are around 0.5% while for the left lobe, it is around 0.1%. Morbidity rates are reported to be around 20% [8] . Some of these include serious bile duct related injuries associated with significant impact on quality of life. Most importantly, these donors are healthy individuals. Based on these observations, some groups from the West discourage LDLT. Even well established centres seem to be moving away from LDLT. Infringement of law may result in imprisonment and cancellation of a license to practice in addition to a substantial fine.
In conclusion LDLT has flourished in Asia and will continue to maintain its momentum. The current goals for new centres should be to maintain high standards, to ensure quality control and to establish a sound legal system. 
